Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...